How Much Did Raydiax Raise?
Funding & Key Investors

Raydiax, an image assistance tomography company specializing in cancer treatments, has secured significant capital, with its total funding reaching $3.7M. The company recently announced a major strategic investment, adding to its financial backing. This latest round of financing underscores the growing interest in innovative medical imaging technologies for oncology.

What is Raydiax?

Raydiax
Healthcare ServicesMedical Laboratories & Imaging Centers

Based in Magdeburg, Raydiax is at the forefront of developing advanced image assistance tomography solutions tailored for cancer treatments. The company's technology aims to enhance diagnostic accuracy and treatment planning in oncology, potentially improving patient outcomes. This focus positions Raydiax within the critical intersection of medical imaging and cancer care, a rapidly evolving sector driven by technological advancements and unmet clinical needs.

How much funding has Raydiax raised?

Raydiax has raised a total of $3.7M across 2 funding rounds:

2023

Grant

$1.2M

Angel/Seed

$2.5M

Grant (2023): $1.2M with participation from German Federal Ministry for Economic Affairs and Climate Action

Angel/Seed (2023): $2.5M led by BMP Ventures

Key Investors in Raydiax

German Federal Ministry for Economic Affairs and Climate Action

The German Federal Ministry for Economic Affairs and Climate Action is a governmental body that supports economic development and climate initiatives within Germany, likely providing grants and funding for innovative research and technology.

BMP Ventures

BMP Ventures is an investment firm that focuses on various holdings and strategic support for its portfolio companies, indicating a role in business development and expansion.

Undisclosed Investor

An undisclosed investor participating in the funding round, suggesting a strategic interest in Raydiax's technology without public disclosure.

What's next for Raydiax?

The recent enterprise-level funding and strategic investment signal a pivotal growth phase for Raydiax. This capital infusion is expected to accelerate product development, expand research initiatives, and potentially scale commercialization efforts. The company's trajectory suggests a strong focus on solidifying its market position and further innovating its tomography technology for broader application in cancer therapy and diagnostics. Future developments will likely center on clinical validation and strategic partnerships to enhance its reach within the healthcare ecosystem.

See full Raydiax company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Healthcare Services industry

Elderly Care ServicesHealthcare Services
Healthcare ServicesVeterinary Services
Healthcare ServicesVeterinary Services
Healthcare ServicesMental Health & Rehabilitation Facilities

Frequently Asked Questions Regarding Raydiax Financial Insights

What are the most recent funding rounds that Raydiax has completed, and what were the funding rounds?
Raydiax has recently completed 2 funding rounds: Grant on Oct 27, 2023, Angel/Seed on Oct 27, 2023.
What is the total amount of funding Raydiax has raised to date?
Raydiax has raised a total of $3.7M in funding to date.
How many funding rounds has Raydiax completed?
Raydiax has completed 2 funding rounds.
How much funding did Raydiax raise in its most recent funding round?
Raydiax raised $1.2M in its most recent funding round.
Who are the lead investors in Raydiax's latest funding round?
The lead investor in Raydiax's latest funding round was German Federal Ministry for Economic Affairs and Climate Action. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Raydiax's history?
The largest funding round in Raydiax's history was $2.5M.
See more information about Raydiax